Giving patients with suspected bladder cancer an MRI scan before surgery could mean they would be treated more quickly, leading to fewer deaths due to the disease, new research suggests. The findings, ...

To make life easier for people with a common bladder condition, Medtronic is digging in far away from urinary tract. Treatment for urinary urge incontinence can require pads, absorbent underwear and ...

A month ago, SCAN Health Plan revealed it would enter a new state with its Medicare Advantage (MA) coverage offerings. Now, the not-for-profit insurer is offering a more detailed look at its slate of ...

For years, Sarah Cossar from South Australia lived with constant urgency and pelvic pain, waking up multiple times a night to wee, but she thought she just had a ‘small bladder’. After learning her ...

The NFL Hall of Famer also discuss why he decided to share the news publicly. Deion Sanders is opening up about a fight that changed his life. The NFL Hall of Famer and Colorado Buffaloes head coach ...

The FDA approved the Altaviva implantable nerve stimulator for urge urinary incontinence (UUI), a common symptom of overactive bladder (OAB), Medtronic announced. Inserted near the ankle in a ...

Hyperscape Capture, a new app for existing Quest 3 and Quest 3S VR headsets, can scan your space in minutes. It's available now. I started with CNET reviewing laptops in 2009. Now I explore wearable ...

The US Food and Drug Administration has approved Johnson & Johnson’s drug delivery system for a type of bladder cancer, offering a potential surgery-free option for patients. The drug release system, ...

The FDA has signed off on Johnson & Johnson’s highly anticipated bladder cancer drug Inlexzo, marking an advance in the ability to care for patients who otherwise face bladder removal and limited ...

Inlexzo is a new treatment for a type of bladder cancer in adults that hasn’t spread to the muscles and doesn’t respond to Bacillus Calmette-Guérin (BCG) therapy. It’s approved for treating non-muscle ...

The FDA has approved a gemcitabine intravesical system for Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS), either with or without ...